Deals
Elroy Air Nears $1B SPAC Via Columbus Circle
Elroy Air's cargo drone, built to replace trucks on middle-mile routes, could hit public markets by Friday via a $1B SPAC with Columbus Circle.
Latest — Page 15
SEC
CFPB Rewires Complaint Portal After 3,700% Surge
CFPB's biggest complaint system overhaul since 2011 pushes consumers to exhaust FCRA rights first. Equifax, Experian, and TransUnion quietly win.
AI
Alibaba Mined Claude 28.8M Times, Anthropic Tells Senate
Anthropic's Senate letter names Alibaba in the largest AI distillation attack ever: 28.8M exchanges, 25,000 fake accounts, after Trump's warning.
Legal
Sued: 400 Papers Allege OpenAI Copyright Theft
Former NJ AG's new firm just sued OpenAI and Microsoft on behalf of nearly 400 newspapers, and the DMCA claim may be the sharper weapon.
Legal
FCC Filed NPRM on $2B E-Rate Sunset Risk
Carr's 2-1 vote puts the $2B E-Rate program on a path to sunset or deep cuts, and the congressional-intent argument could next reach Lifeline.
Legal
EU Flags AWS, Azure as Cloud Gatekeepers
For the first time, EU cloud rules could bind AWS and Azure, even though neither company cleared the DMA's standard numeric thresholds.
AI
Cut from Mythos 5, EU Confronts White House on Anthropic
After a Fable 5 jailbreak scare yanked Mythos 5 from ENISA's hands overnight, the EU's top tech official flew to D.C. to get it back.
Legal
Sentenced: DraftKings Hacker Snoopy Owes $1.79M
DraftKings hacker Snoopy ran a shop selling stolen accounts, pocketed $465K in crypto, and now owes $1.79M in forfeiture and restitution.
SEC
CFPB Tightens Complaint Portal After 3,700% Surge
Credit repair clinics turned the CFPB portal into a revenue engine. New triage rules could shut that down and snag legitimate disputes too.
Legal
Filed Under RICO, Microsoft Cuts 326 Cybercrime Servers
Microsoft's RICO filing merged two separate malware families into one conspiracy; the takedown hit 326 servers and froze $47M in criminal crypto.
FDA
WHO Deploys Gilead, Mapp Antivirals After 277 DRC Deaths
Gilead's remdesivir and Mapp's MBP134 enter their first DRC trial against Bundibugyo ebolavirus, where 277 have died and no licensed treatment exists.
FDA
Cut 17%: ADC Therapeutics After 27 Zynlonta Deaths
Twenty-seven deaths in Zynlonta's Phase 3 confirmatory trial wiped out 66% of ADC Therapeutics' market cap and 17% of its workforce.
FDA
FDA Cited Jubilant for Six-Month Mold Investigation Lag
When a cleanroom operator's neck swab came back at 83 colony-forming units, Jubilant's sterile plant had already been sitting on the trend for months.
AI
Check Your SaaS Contract: 92% Claim AI Training Rights
TermScout analysis: 92% of AI contracts claim data rights beyond service delivery. You signed an AI training license at SaaS onboarding.
Legal
Remanded: Jackson to Rule on CFPB's 556-Employee Plan
Judge Jackson's expedited CFPB remand pits a 556-employee restructuring plan against a $677M injunction compliance gap and new funding caps.
